The rapid expansion of the illicit synthetic drug trade is reshaping the global narcotics market and intensifying a public health crisis, according to the International Narcotics Control Board (INCB).
In its 2024 Annual Report, released on Tuesday, March 3, the UN-administered body highlighted the dangers posed by synthetic substances, which are cheaper and easier to manufacture than traditional plant-based drugs.
Unlike heroin or cocaine, which require large-scale cultivation, synthetic drugs can be produced anywhere using chemical precursors. This flexibility has made them the drug of choice for traffickers, who now rely on these substances to dominate the global black market.
The rise of potent opioids like fentanyl and nitazenes has worsened the crisis, driving overdose deaths to record highs. In 2022, 73,654 people died from a fentanyl overdose in the US alone, more than double the amount of deaths from three years prior in 2019.
“The rapid expansion of the illicit synthetic drug industry represents a major global public health threat with potentially disastrous consequences for humankind.
“We need to work together to take stronger action against this deadly problem which is causing hundreds of deaths and untold harm to communities.”
INCB President Jallal Toufiq.
Criminal networks have adapted swiftly to evade law enforcement. By exploiting legal loopholes, they continuously develop new synthetic compounds and use artificial intelligence to identify alternative chemicals that can be used in drug production. Traffickers also utilize advanced smuggling techniques, including drones and postal deliveries, making detection increasingly difficult.
Despite ongoing efforts to curb synthetic drugs, regulatory responses remain fragmented, allowing traffickers to stay ahead. The INCB is calling for stronger international cooperation, urging governments, private companies, and global organizations to work together to disrupt supply chains and mitigate harm.
The illicit synthetic drugs trade has evolved into a highly lucrative and sophisticated global market, with an estimated value of billions of dollars. Recent operations, such as INTERPOL’s Operation Lionfish Mayag II, have highlighted the scale of this trade, with seizures valued at over USD 1.05 billion.
Millions Lack Access to Essential Pain Medication
While synthetic drugs flood illegal markets, millions in low- and middle-income countries continue to suffer without access to essential pain relief medication. The report highlights a stark contrast: opioid painkillers like morphine remain unavailable in regions such as Africa, South Asia, and Central America — not due to shortages, but because of strict regulatory barriers and distribution challenges.
The INCB is urging opioid-producing nations to scale up production and affordability to enhance palliative care and pain management worldwide. The lack of accessible pain medication remains a critical issue, particularly in countries with high rates of terminal illnesses and post-surgical patients.
The 2024 Annual Report also identifies several key regions where synthetic drug trafficking is expanding. In Europe, Afghanistan’s 2022 opium ban has created a heroin shortage, increasing the likelihood that users will turn to synthetic alternatives. Meanwhile, in North America, despite extensive efforts to control the crisis, deaths related to synthetic opioids remain at unprecedented levels.
In the Middle East and Africa, the production and trafficking of amphetamine-type stimulants are on the rise, exacerbated by limited access to rehabilitation and treatment services. The Asia-Pacific region has also witnessed significant growth in methamphetamine and ketamine trafficking, particularly in the Golden Triangle, a notorious hub for illicit drug trade.
The INCB is pushing for stronger global collaboration, improved data-sharing, and expanded drug prevention and treatment programs. Without decisive intervention, the synthetic drug trade will continue to evolve, placing millions of lives at risk.
Without stronger regulatory frameworks and global cooperation, the synthetic drug trade will remain a dominant force in the illicit narcotics market, endangering countless lives and undermining efforts to control drug-related harm.
READ ALSO: Scrapping SHS Cut-Offs: A Call for Inclusive Secondary Education
